Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy

Dermatology

Volumn 218, Issue 3, 2009, Pages 193-202

  Gerritsen, M J P ^a   Smits, T ^a   Kleinpenning, M M ^a   Van De Kerkhof, P C M ^a   Van Erp, P E J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adjuvant treatment; Literature review; Photodynamic therapy

Indexed keywords

1,2 DIETHYL 3 HYDROXY 4 PYRIDONE; 3 HYDROXY 4 PYRIDONE DERIVATIVE; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DEFEROXAMINE; DIMETHYL SULFOXIDE; EDETIC ACID; ERBIUM; GLYCOLIC ACID; HEMATOPORPHYRIN DERIVATIVE; IRON CHELATING AGENT; KERATOLYTIC AGENT; LAUROCAPRAM; OLEIC ACID; PENETRATION ENHANCING AGENT; PETROLATUM; PROTOPORPHYRIN; SALICYLIC ACID DERIVATIVE; YTTRIUM;

ADJUVANT THERAPY; BASAL CELL CARCINOMA; BIOACCUMULATION; BOWEN DISEASE; CANCER MODEL; CANCER SURGERY; CLINICAL TRIAL; CURETTAGE; CYTOREDUCTIVE SURGERY; DIODE LASER; DRUG EFFECT; DRUG EFFICACY; DRUG INSTILLATION; DRUG PENETRATION; DRUG SAFETY; DRUG UPTAKE; HUMAN; HYPERKERATOSIS; IONTOPHORESIS; LASER SURGERY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; REVIEW; SINGLE DRUG DOSE; SKIN ABRASION; SKIN CANCER; SKIN CARCINOMA; SKIN DEFECT; SKIN DISEASE; SKIN TEMPERATURE; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM; TREATMENT OUTCOME; TREATMENT RESPONSE; VERRUCA PLANTARIS; VERRUCA VULGARIS;

AMINOLEVULINIC ACID; ANIMALS; HUMANS; KERATOSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN;

EID: 62049083991     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000183753     Document Type: Review

References (38)

1. Kleinpenning MM, Smits T, Ewalds E, van Erp PE, van de Kerkhof PC, Gerritsen MJ: Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. Br J Dermatol 2006;155:539-545.
2. Smits T, Kleinpenning MM, Blokx WA, van de Kerkhof PC, van Erp PE, Gerritsen MJ: Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Dermatol 2007;57:824-831.
3. Smits T, Robles CA, van Erp PE, van de Kerkhof PC, Gerritsen MJ: Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 2005;125:833-839.
4. Ibbotson SH, Jong C, Lesar A, et al: Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Photodermatol Photoimmunol Photomed 2006;22:105-110.
5. Katz BE, Truong S, Maiwald DC, Frew KE, George D: Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT. J Drugs Dermatol 2007;6:140-142.
6. Shen SC, Lee WR, Fang YP, Hu CH, Fang JY: In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. J Pharm Sci 2006;95:929-938.
7. Souza CS, Neves AB, Felicio LA, Ferreira J, Kurachi C, Bagnato VS: Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers. Dermatol Surg 2007;33:194-198.
8. Thissen MR, Schroeter CA, Neumann HA: Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000;142:338-339.
9. Berroeta L, Clark C, Dawe RS, Ibbotson SH, Fleming CJ: A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. Br J Dermatol 2007;157:401-403.
10. Itoh Y, Henta T, Ninomiya Y, Tajima S, Ishibashi A: Repeated 5-aminolevulinic acid-based photodynamic therapy following electro-curettage for pigmented basal cell carcinoma. J Dermatol 2000;27:10-15.
11. Soler AM, Warloe T, Berner A, Giercksky KE: A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001;145:467-471.
12. Soler AM, Warloe T, Tausjo J, Berner A: Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm Venereol 1999;79:204-206.
13. Ziolkowski P, Osiecka BJ, Siewinski M, Bronowicz A, Ziolkowska J, Gerber-Leszczyszyn H: Pretreatment of plantar warts with azone enhances the effect of 5-aminolevulinic acid photodynamic therapy. J Environ Pathol Toxicol Oncol 2006;25:403-409.
14. De Rosa FS, Marchetti JM, Thomazini JA, Tedesco AC, Bentley MV: A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy. J Control Release 2000;65:359-366.
15. Ziolkowski P, Osiecka BJ, Oremek G, et al: Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol 2004;4:121-129.
16. Pierre MB, Ricci E Jr, Tedesco AC, Bentley MV: Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res 2006;23:360-366.
17. Bodde HE, Roemele PE, Star WM: Quantification of topically delivered 5-aminolevulinic acid by lontophoresis across ex vivo human stratum corneum. Photochem Photobiol 2002;75:418-423.
18. Gelfuso GM, Figueiredo FV, Gratieri T, Lopez RF: The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4). J Pharm Sci 2008;97:4249-4257.
19. Rhodes LE, Tsoukas MM, Anderson RR, Kollias N: Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 1997;108:87-91.
20. Ramstad S, Le Anh-Vu N, Johnsson A: The temperature dependence of porphyrin production in Propionibacterium acnes after incubation with 5-aminolevulinic acid (ALA) and its methyl ester (m-ALA). Photochem Photobiol Sci 2006;5:66-72.
21. van den Akker JT, Boot K, Vernon DI, et al: Effect of elevating the skin temperature during topical ALA application on in vitro ALA penetration through mouse skin and in vivo PpIX production in human skin. Photochem Photobiol Sci 2004;3:263-267.
22. Liu HF, Xu SZ, Zhang CR: Influence of CaNa 2 EDTA on topical 5-aminolaevulinic acid photodynamic therapy. Chin Med J (Engl) 2004;117:922-926.
23. Berg K, Anholt H, Bech O, Moan J: The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Br J Cancer 1996;74:688-697.
24. Malik Z, Kostenich G, Roitman L, Ehrenberg B, Orenstein A: Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J Photochem Photobiol B 1995;28:213-218.
25. Fang JY, Lee WR, Shen SC, Fang YP, Hu CH: Enhancement of topical 5-aminolaevulinic acid delivery by erbium: YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 2004;151:132-140.
26. Lopez RF, Bentley MV, Begona Delgado-Charro M, Guy RH: Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 2003;88:65-70.
27. Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J: Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin. Photochem Photobiol 2002;76:452-456.
28. Juzeniene A, Juzenas P, Bronshtein I, Vorobey A, Moan J: The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid. J Photochem Photobiol B 2006;84:161-166.
29. Donnelly RF, Morrow DI, McCarron PA, et al: Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release 2008;129:154-162.
30. Ma L, Moan J, Peng Q, Iani V: Production of protoporphyrin IX induced by 5-aminolevulinic acid in transplanted human colon adenocarcinoma of nude mice can be increased by ultrasound. Int J Cancer 1998;78:464-469.
31. Uehlinger P, Ballini JP, van den BH, Wagnieres G: On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin. Photochem Photobiol 2006;82:1069-1076.
32. Choudry K, Brooke RC, Farrar W, Rhodes LE: The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 2003;149:124-130.
33. Curnow A, Pye A: Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors. J Environ Pathol Toxicol Oncol 2007;26:89-103.
34. Curnow A, MacRobert AJ, Bown SG: Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid. Lasers Surg Med 2006;38:325-331.
35. Pye A, Campbell S, Curnow A: Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma. J Cancer Res Clin Oncol 2008;134:841-849.
36. Campbell SM, Morton CA, Alyahya R, Horton S, Pye A, Curnow A: Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Br J Dermatol 2008;159:387-393.
37. Moseley H, Brancaleon L, Lesar AE, Ferguson J, Ibbotson SH: Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo? Photodermatol Photoimmunol Photomed 2008;24:72-75.
38. Soler AM, Angell-Petersen E, Warloe T, et al: Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol 2000;71:724-729.